Multiscale models of the antimicrobial peptide protegrin-1 on gram-negative bacteria membranes

International Journal of Molecular Sciences

Volumn 13, Issue 9, 2012, Pages 11000-11011

  Bolintineanu, Dan S ^a   Vivcharuk, Victor ^a   Kaznessis, Yiannis N ^a  

^a University of Minnesota   (United States)

Author keywords

Antimicrobial peptides; Ion transport; Molecular simulations; Multiscale models; Peptide membrane interactions; Protegrin

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT; PROTEGRIN; PROTEGRIN 1; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; ION CHANNEL; PROTEGRIN-1;

BACTERIAL MEMBRANE; DIFFUSION; DIMERIZATION; DRUG MECHANISM; DRUG SPECIFICITY; GRAM NEGATIVE BACTERIUM; ION PERMEABILITY; LIPID BILAYER; MEMBRANE BINDING; MEMBRANE COMPONENT; MEMBRANE CONDUCTANCE; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; POTASSIUM TRANSPORT; PROTEIN AGGREGATION; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REVIEW; STATISTICAL MODEL; THERMODYNAMICS; BIOSYNTHESIS; CELL MEMBRANE; CHEMICAL STRUCTURE; DRUG EFFECTS; ION TRANSPORT; MICROBIAL SENSITIVITY TEST; THEORETICAL MODEL;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL MEMBRANE; GRAM-NEGATIVE BACTERIA; ION CHANNELS; ION TRANSPORT; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MODELS, THEORETICAL; MOLECULAR DYNAMICS SIMULATION; THERMODYNAMICS;

EID: 84866913498     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms130911000     Document Type: Review

References (40)

1. Boucher, H.W.; Talbot, G.H.; Bradley, J.S.; Edwards, J.E.; Gilbert, D.; Rice, L.B.; Scheld, M.; Spellberg, B.; Bartlett, J. Bad bugs, no drugs: No ESKAPE! An update from the infectious diseases society of america. Clin. Infect. Dis. 2009, 48, 1-12.
2. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415, 389-395.
3. Brogden, K.A. Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 2005, 3, 238-250.
4. Kokryakov, N.V.; Harwig, S.S.L.; Panyutich, E.A.; Shevchenko, A.A.; Aleshina, G.M.; Shamova, O.V.; Korneva, H.A.; Lehrer, R.I. Protegrins: Leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett. 1993, 327, 231-236.
5. Mangoni, M.E.; Aumelas, A.; Charnet, P.; Roumestand, C.; Chiche, L.; Despaux, E.; Grassy, G.; Calas, B.; Chavanieu, A. Change in membrane permeability induced by protegrin 1: Implication of disulphide bridges for pore formation. FEBS Lett. 1996, 383, 93-98.
6. Sokolov, Y.; Mirzabekov, T.; Martin, D.W.; Lehrer, R.I.; Kagan, B.L. Membrane channel formation by antimicrobial protegrins. Biochim. Biophys. Acta 1999, 1420, 23-29.
7. Neville, F.; Ishitsuka, Y.; Hodges, C.S.; Konovalov, O.; Waring, A.J.; Lehrer, R.; Lee, K.Y.; Gidalevitz, D. Protegrin interaction with lipid monolayers: Grazing incidence X-ray diffraction and X-ray reflectivity study. Soft Matter 2008, 4, 1665-1674.
8. Gidalevitz, D.; Ishitsuka, Y.; Muresan, A.S.; Konovalov, O.; Waring, A.J.; Lehrer, R.I.; Lee, K.Y. Interaction of antimicrobial peptide protegrin with biomembranes. Proc. Natl. Acad Sci. USA 2003, 100, 6302-6307.
9. Langham, A.A.; Ahmad, A.S.; Kaznessis, Y.N. On the nature of antimicrobial activity: A model for protegrin-1 pores. J. Am. Chem. Soc. 2008, 130, 4338-4346.
10. Bolintineanu, D.S.; Hazrati, E.; Davis, H.T.; Lehrer, R.I.; Kaznessis, Y.N. Antimicrobial mechanism of pore-forming protegrin peptides: 100 pores to kill E. coli. Peptides 2010, 31, 1-8.
11. Bolintineanu, D.S.; Kaznessis, Y.N. Computational studies of protegrin antimicrobial peptides: A review. Peptides 2011, 32, 188-201.
12. Vivcharuk, V.; Kaznessis, Y. Free energy profile of the interaction between a monomer or a dimer of protegrin-1 in a specific binding orientation and a model lipid bilayer. J. Phys. Chem. B 2010, 114, 2790-2797.
13. Vivcharuk, V.; Kaznessis, Y.N. Dimerization of protegrin-1 in different environments. Int. J. Mol. Sci. 2010, 11, 3177-3194.
14. Vivcharuk, V.; Kaznessis, Y. Thermodynamic Analysis of Protegrin-1 Insertion and Permeation through a Lipid Bilayer. 2011, 115, 14704-14712.
15. Kaznessis, Y.N. Statistical Thermodynamics and Stochastic Kinetics; Cambridge University Press: Cambridge, UK, 2012.
16. Talbot, J. Molecular thermodynamics of binary mixture adsorption: A scaled particle theory approach. J. Chem. Phys. 1997, 106, 4696-4706.
17. Zuckermann, M.J.; Heimburg, T. Insertion and pore formation driven by adsorption of proteins onto lipid bilayer membrane-water interfaces. Biophys. J. 2001, 81, 2458-2472.
18. Reiss, H.; Frisch, H.L.; Lebowitz, J.L. Statistical mechanics of rigid spheres. J. Chem. Phys. 1959, 31, 369-380.
19. Matsuzaki, K.; Murase, O.; Fujii, N.; Miyajima, K. An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry 1996, 35, 11361-11368.
20. Huang, H.W.; Chen, F.Y.; Lee, M.T. Molecular mechanism of peptide-induced pores in membranes. Phys. Rev. Lett. 2004, 92, 198304.
21. Mani, R.; Cady, S.D.; Tang, M.; Waring, A.J.; Lehrer, R.I.; Hong, M. Membrane-dependent oligomeric structure and pore formation of a beta-hairpin antimicrobial peptide in lipid bilayers from solid-state NMR. Proc. Natl. Acad Sci. USA 2006, 103, 16242-16247.
22. Bolintineanu, D.S.; Sayyed-Ahmad, A.; Davis, H.T.; Kaznessis, Y.N. Poisson-Nernst-Planck models of nonequilibrium ion electrodiffusion through a protegrin transmembrane pore. PLoS Comput. Biol. 2009, 5, e1000277.
23. Langham, A.; Kaznessis, Y.N. Molecular simulations of antimicrobial peptides. Methods Mol. Biol. 2010, 618, 267-285.
24. Sayyed-Ahmad, A.; Kaznessis, Y.N. Determining the orientation of protegrin-1 in DLPC bilayers using an implicit solvent-membrane model. PLoS One 2009, 4, e4799.
25. Langham, A.A.; Khandelia, H.; Schuster, B.; Waring, A.; Lehrer, R.; Kaznessis, Y. Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: Predicting experimental toxicity. Peptides 2008, 29, 1085-1093.
26. Bolintineanu, D.S.; Langham, A.; Davis, T.H.; Kaznessis, Y. Molecular dynamics simulations of three protegrin-type anti-microbial peptides: interplay between charges at the termini, beta-sheet structure and amphiphilic interactions. Mol. Simul. 2007, 33, 809-819.
27. Langham, A.A.; Waring, A.J.; Kaznessis, Y. Comparison of interactions between beta-hairpin decapeptides and SDS/DPC micelles from experimental and simulation data. BMC Biochem. 2007, 8, 11.
28. Khandelia, H.; Kaznessis, Y. Structure of the antimicrobial beta-hairpin peptide protegrin-1 in a DLPC lipid bilayer investigated by molecular dynamics Simulation. Biochim. Biophys. Acta 2007, 1768, 509-520.
29. Khandelia, H.; Kaznessis, Y. Cation-π Interactions stabilize the structure of the antimicrobial peptide indolicidin near membranes: Molecular dynamics simulations. J. Phys. Chem. B 2007, 111, 242-250.
30. Langham, A.A.; Kaznessis, Y. Effects of mutations on the C-terminus of protegrin-1: A molecular dynamics simulation study. Mol. Simul. 2006, 32, 193-201.
31. Khandelia, H.; Langham, A.; Kaznessis, Y. Driving engineering of novel antimicrobial peptides from simulations of peptide-micelle interactions. Biochim. Biophys. Acta 2006, 1758, 1224-1234.
32. Khandelia, H.; Kaznessis, Y. Molecular dynamics investigation of the influence of anionic and zwitterionic interfaces on antimicrobial peptides' structure: Implications on peptide toxicity and activity. Peptides 2006, 27, 1192-1200.
33. Langham, A.A.; Khandelia, H.; Kaznessis, Y. How can protegrin-1 be both a potent antimicrobial and harmfully toxic? Molecular dynamics simulations of a beta-sheet antimicrobial peptide in micelles. Biopolym. Pept. Sci. 2006, 84, 219-231.
34. Khandelia, H.; Kaznessis, Y. Molecular dynamics simulations of helical antimicrobial peptides in SDS micelles: What do point mutations achieve? Peptides 2005, 26, 2037-2049.
35. Sayyed-Ahmad, A.; Khandelia, H.; Kaznessis, Y.N. Relative free energy of binding between antimicrobial peptides and SDS or DPC micelles. Mol. Simul. 2009, 35, 986-997.
36. Langham, A.; Kaznessis, Y. Molecular dynamics simulations of the N-terminus of HIV GP-41 fusion peptide in SDS micelles. J. Pept. Sci. 2005, 14, 316-328.
37. Ostberg, N.; Khandelia, H.; Kaznessis, Y. Protegrin structure activity relationships: Using homology models of synthetic sequences to determine structural characteristics important for activity. Peptides 2005, 26, 297-306.
38. Mulakala, C.; Lambris, J.D.; Kaznessis, Y. A simple, yet highly accurate, QSAR model captures the complement inhibitory activity of compstatin. Bioorg. Med. Chem. 2007, 15, 1638-1644.
39. Wang, W.; Mulakala, C.; Ward, S.C.; Jung, G.; Luong, H.; Pham, D.; Waring, A.J.; Kaznessis, Y.; Lu, W.; Bradley, K.A.; et al. Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin. J. Biol. Chem. 2006, 281, 32755-32764.
40. Chiu, T.-L.; Mulakala, C.; Lambris, J.D.; Kaznessis, Y.N. Development of a new pharmacophore model that discriminates active compstatin analogs. Chem. Biol. Drug Des. 2008, 72, 249-256.